Dr Robert Eckel reviews research from ADA 2017 on alirocumab in patients with diabetes and mixed dyslipidemia.

Dr Alan Jacobs reviews a pilot study's intriguing results.

Dr David Johnson looks at two new reports that may dismiss this association, thereby relieving our patients' worrying.

These new insulin options are more expensive, so it's important to know where they will provide the most benefit.

Drs Harrington and Kesselheim discuss the varied reasons why prescription drugs are so pricey and whether policies can interrupt this alarming trend.

Dr Peter Yellowlees talks about a new study that compares buprenorphine with other agents for management of opioid withdrawal.

Dr Alan Jacobs discusses a recently published report suggesting that dietary inclusion of omega-3 could improve cognitive function.

These evidence-based tips can increase the likelihood of vaccine acceptance.

Dr Califf talks about his new role at Verily and how data mining and data sharing could reduce disparities in care and improve patient outcomes.

Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says.